Pulse 探索 nav.journalClub 議論トレンド研究者

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

ホーム探索 nav.journalClub トレンド

⌘+K

Stephan Herbertz | Synapse

SH

Stephan Herbertz

Lung Cancer Treatments and Mutations

Boehringer Ingelheim (Germany)

About

Research focus

Lung Cancer Treatments and Mutations

Impact

11 pubs · 1,385 cites · h-index 7

Affiliations

Work Experience

Boehringer Ingelheim (Germany)

2025 - 2025

Boehringer Ingelheim (China)

2024 - 2024

Eli Lilly (Germany)

2015 - 2018

Novartis (Germany)

2011 - 2011

German Cancer Research Center

1999 - 2002

Publications